Skip to main content

Peer Review reports

From: Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin

Original Submission
3 Feb 2016 Submitted Original manuscript
20 Jul 2016 Reviewed Reviewer Report - Zsuzsanna Tabi
1 Aug 2016 Reviewed Reviewer Report - Robert Cameron
1 Aug 2016 Reviewed Reviewer Report - Junya Fujimoto
25 Aug 2016 Author responded Author comments - Guntulu Ak
Resubmission - Version 2
25 Aug 2016 Submitted Manuscript version 2
9 Sep 2016 Reviewed Reviewer Report - Zsuzsanna Tabi
11 Sep 2016 Reviewed Reviewer Report - Junya Fujimoto
28 Oct 2016 Reviewed Reviewer Report - Robert Cameron
2 Dec 2016 Author responded Author comments - Guntulu Ak
Resubmission - Version 3
2 Dec 2016 Submitted Manuscript version 3
21 Feb 2017 Author responded Author comments - Guntulu Ak
Resubmission - Version 4
21 Feb 2017 Submitted Manuscript version 4
Publishing
21 Mar 2017 Editorially accepted
23 Mar 2017 Article published 10.1186/s12885-017-3209-5

You can find further information about peer review here.

Back to article page